Comment | Published:

MK2 puts an additional brake on RIPK1 cytotoxic potential

Cell Death & Differentiationvolume 25pages457459 (2018) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Edited by G. Melino

References

  1. 1.

    Linkermann A, Green DR. Necroptosis. N. Eng. J. Med. 2014;370:455–65.

  2. 2.

    Dondelinger Y, et al. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ. 2013;20:1381–92.

  3. 3.

    Silke J, et al. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015;16:689–97.

  4. 4.

    Menon MB, et al. p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection. Nat Cell Biol. 2017;19:1248–59.

  5. 5.

    Jaco I, et al. MK2 phosphorylates RIPK1 to prevent TNF-induced cell death. Mol Cell. 2017;66:698–710. e695.

  6. 6.

    Dondelinger Y, et al. MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat Cell Biol. 2017;19:1237–47.

  7. 7.

    Ting AT, Bertrand MJ. More to life than NF-κB in TNFR1 signaling. Trends Immunol. 2016;37:535–45.

  8. 8.

    Dondelinger Y, et al. NF-κB-independent role of IKKα/IKKβ in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol Cell. 2015;60:63–76.

  9. 9.

    Vlantis K, et al. NEMO prevents RIP Kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-κB-dependent and -independent functions. Immunity. 2016;44:553–67.

  10. 10.

    Koppe C, et al. IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1. Hepatology. 2016;64:1217–31.

  11. 11.

    Mohideen F, et al. Quantitative phospho-proteomic analysis of TNFα/NFκB signaling reveals a role for RIPK1 phosphorylation in suppressing necrotic cell death. Mol Cell Proteomics. 2017;16:1200–16.

  12. 12.

    Geng J, et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun. 2017;8:359.

  13. 13.

    Peterson LW, et al. RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense. J Exp Med. 2017;214:3171–3182.

  14. 14.

    Croft M, Siegel RM. Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases. Nat Rev Rheumatol. 2017;13:217–33.

  15. 15.

    Kawashima R, et al. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis. Gastroenterology. 2011;141:2119–29. e2118.

Download references

Author information

Affiliations

  1. VIB Center for Inflammation Research, Technologiepark 927, 9052, Zwijnaarde-Ghent, Belgium

    • Yves Dondelinger
    • , Tom Delanghe
    •  & Mathieu M. J. Bertrand
  2. Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, 9052, Zwijnaarde-Ghent, Belgium

    • Yves Dondelinger
    • , Tom Delanghe
    •  & Mathieu M. J. Bertrand

Authors

  1. Search for Yves Dondelinger in:

  2. Search for Tom Delanghe in:

  3. Search for Mathieu M. J. Bertrand in:

Conflict of interest

The authors declare that they have no competing interests.

Corresponding author

Correspondence to Mathieu M. J. Bertrand.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41418-017-0009-z